FlyteHealth
FlyteHealth is a tech-enabled healthcare services company that delivers AI-driven cardio-kidney-metabolic and obesity care to self-insured employers, health plans, and Medicare Advantage buyers on a per-covered-life subscription model.
- Company typePrivate
- Founded2012
- HeadquartersNew Canaan, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What FlyteHealth does
FlyteHealth is a tech-enabled healthcare services company that delivers cardio-kidney-metabolic (CKM) care to self-insured employers, health plans, and individual patients, with a primary focus on obesity treatment. Founded in 2012 as Intellihealth by obesity medicine pioneers Dr. Louis Aronne and Dr. Katherine Saunders, the company rebranded to FlyteHealth in July 2024 and is headquartered in New Canaan, CT. Its core platform combines board-certified obesity medicine physicians, a multidisciplinary care team, and the patent-pending Flyte Intelligence AI engine, which drives an AI prescribing model and a patient-acuity prioritization model that direct more than 70% of patients to non-GLP-1 medications while reserving high-cost GLP-1s for highest-need cases. The product suite includes the FlyteHealth patient mobile app, comprehensive patient evaluation (labs, PHQ-8, SDOH), and connected eCKM programs built around the CDC's Diabetes Prevention Program framework, delivered via a five-pillar care model (scientific validation, expert medical care, personalized planning, behavioral support, AI-driven precision).
FlyteHealth operates a B2B enterprise subscription model, charging self-insured employers and health plans on a per-covered-life basis (approximately $1,800 per eligible member per year, with modeled savings of $2,006 per enrolled member per year). Go-to-market combines direct enterprise sales with broker/consultant partnerships (USI, Mercer, NFP, AON, WTW, Gallagher, Segal) and, more recently, ecosystem partnerships with SmithRx (PBM) and Eli Lilly's Employer Connect platform, the latter providing access to Zepbound at $449 per dose. Reported clinical outcomes include 13-16% average weight loss at 12 months, 86% GLP-1 adherence, 7.2% HbA1c reduction, and 9.4% blood glucose reduction; the State of Connecticut Health Plan partnership has enrolled 11,500+ members and generated $100 PMPM in medical savings and $29.7M in pharmacy cost avoidance in FY 2024-2025. The company maintains SOC 2 Type I, HITRUST, and HIPAA certifications and was selected for the CMS Health Tech Ecosystem in the Diabetes and Obesity category in June 2026, opening a Medicare Advantage go-to-market.
FlyteHealth firmographics
Firmographics- Name
- FlyteHealth
- Legal name
- Intellihealth, Inc.
- Website
- https://flytehealth.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- FlyteHealth is a tech-enabled healthcare services company that delivers AI-driven cardio-kidney-metabolic and obesity care to self-insured employers, health plans, and Medicare Advantage buyers on a per-covered-life subscription model.
- Ownership category
- akta.pro rank
FlyteHealth industry classification
Industry- Product category
- Obesity and Cardiometabolic Care Services
- NAICS
- Diet and Weight Reducing Centers (812191)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Obesity Medicine & Weight Management (HLAKADAL)
- akta.pro secondary industries
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ), Weight Loss Coaching (Non-Clinical) (HSADAFAB)
Keywords
Where FlyteHealth is headquartered
LocationHeadquarters
- HQ city
- New Canaan
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
FlyteHealth business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Subscription/Per Covered Life: FlyteHealth generates revenue through subscription fees based on covered lives enrolled in their CKM care program. Pricing model is B2B, with employers and health plans paying per member per month or annual subscription.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription pricing for self-insured employers |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
FlyteHealth product offering
Product offeringCore offering
FlyteHealth provides an AI-driven early cardio-kidney-metabolic (eCKM) care platform that delivers comprehensive obesity and cardiometabolic treatment to populations covered by self-insured employers, health plans, and government plans. The offering combines patent-pending Flyte Intelligence prescribing algorithms with a multidisciplinary clinical care team (board-certified obesity medicine physicians, dietitians, and behavioral support) and a patient-facing mobile app, sold on a per-covered-life subscription basis with documented outcomes of 13–16% average weight loss at 12 months and measurable pharmacy cost avoidance.
Product overview
FlyteHealth is a unified cardio-kidney-metabolic care platform offering comprehensive early CKM (eCKM) care for employers and health plans. The core platform is powered by the patent-pending Flyte Intelligence AI platform, which drives medication protocols and personalized treatment plans. The product portfolio includes the FlyteHealth Patient App for patient engagement and telehealth, the Connected eCKM Programs spanning lifestyle support through clinical treatment, comprehensive patient evaluation (including PHQ-8 and SDOH assessments), and the Weight Matters educational podcast hosted by founding obesity medicine experts Dr. Louis Aronne and Dr. Katherine Saunders. The Five-Pillar Care Model integrates scientific validation, expert medical care, personalized planning, behavioral support, and AI-driven precision. FlyteHealth was rebranded from Intellihealth in July 2024.
Differentiator
Problem solved
Functional benefit
Brands
- Flyte Intelligence: Patent-pending AI-powered obesity treatment platform that drives medication protocols and care plans, enabling cost-effective treatment.
- Weight Matters
Products and services
- FlyteHealth Platform (Early CKM Care Platform) Comprehensive early cardio-kidney-metabolic (eCKM) care platform that helps self-insured employers, health plans, and government plans improve outcomes, reduce costs, and support healthier populations by addressing hypertension, hyperlipidemia, prediabetes, obesity, and other cardiometabolic risk factors. Delivered on a per-covered-life subscription to organizational buyers.
- Flyte Intelligence AI Platform Patent-pending AI platform that drives medication protocols and personalized care plans, enabling over 70% non-GLP-1 medication usage for cost savings while ensuring patients with the highest clinical need receive appropriate treatment intensity via its Acuity Model. Powers the FlyteHealth Platform offering.
- Connected Early Cardio-Kidney-Metabolic (eCKM) Programs Comprehensive care spanning lifestyle support to clinical treatment and long-term maintenance. The lifestyle program follows the CDC's Diabetes Prevention Program (DPP) framework and is offered independently or as part of the connected model to lower total cost of care.
- FlyteHealth Patient Mobile Application Mobile application providing patient access to the FlyteHealth care team, treatment plans, progress tracking, telehealth services, and secure messaging with clinical staff.
Quantifiable outcome
- 13-16% average weight loss at 12 months
- +6 more outcomes
Companies that use FlyteHealth
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles3 records
FlyteHealth technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature3 records
FlyteHealth partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and flagship.
- SmithRxcoreFlyteHealth is part of SmithRx's best-in-class partner ecosystem for GLP-1 programs, helping employers deliver sustainable and clinically appropriate obesity and weight management coverage using manufacturer-approved pricing and transparent PBM model.
- Centers for Medicare & Medicaid Services (CMS)coreFlyteHealth selected for CMS Health Tech Ecosystem directory in the Diabetes and Obesity category, serving as a curated reference for Medicare Advantage organizations and CMS-affiliated health plans.
- Eli LillycoreFlyteHealth is a partner in Eli Lilly's Employer Connect platform, offering employers tailored obesity coverage options including access to Zepbound KwikPen at $449 per dose across all strengths.
- State of Connecticut Health PlanflagshipMulti-year partnership providing Comprehensive Obesity Care program to State of Connecticut health plan members and retirees. Program has enrolled over 11,500 members and generated significant cost savings.
- USIcoreBenefits broker partner representing employer clients seeking obesity and CKM care solutions
- MercercoreBenefits broker partner representing employer clients seeking obesity and CKM care solutions
- NFPcoreBenefits broker partner representing employer clients seeking obesity and CKM care solutions
- AONcoreBenefits broker partner representing employer clients seeking obesity and CKM care solutions
- WTWcoreBenefits broker partner representing employer clients seeking obesity and CKM care solutions
- GallaghercoreBenefits broker partner representing employer clients seeking obesity and CKM care solutions
- SegalcoreBenefits broker partner representing employer clients seeking obesity and CKM care solutions. Segal Group also conducted independent evaluation of Connecticut partnership results.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
FlyteHealth competitors and assessment
Company assessmentEmerging players
- Ilant Health: Emerging employer- and health-plan-focused obesity care company combining clinical treatment with GLP-1 access. Comparable to FlyteHealth on obesity-only specialty, enterprise GTM, and payer-broker distribution; earlier stage with less proven clinical outcomes data.
- Mochi Health: Telehealth obesity medicine practice prescribing GLP-1s and providing physician-led care, with employer partnerships. Comparable to FlyteHealth on obesity-specialist-led virtual care and GLP-1 focus; smaller scale and earlier stage in enterprise channel development.
Direct peers
- Omada Health: Digital cardiometabolic care platform serving self-insured employers and health plans with programs spanning diabetes prevention, hypertension, and weight management. Closely comparable to FlyteHealth in buyer segment, B2B2C distribution model, and chronic-condition orientation; Omada is significantly larger and more broadly deployed across chronic conditions.
- Found: Telehealth obesity care platform with medication (including GLP-1s) and behavior change, primarily D2C with growing employer offerings. Comparable to FlyteHealth on obesity-focused, GLP-1-capable virtual care model; primarily consumer-acquired rather than employer-anchored.
- Form Health: Obesity medicine practice providing physician-supervised care including GLP-1 medications, sold via self-pay and employer partnerships. Comparable to FlyteHealth on board-certified obesity medicine physician leadership and intensive GLP-1-inclusive care; smaller scale and less enterprise-channel development.
- Virta Health: Telehealth platform providing physician-led obesity and type 2 diabetes reversal care to employers, health plans, and government payers. Highly comparable to FlyteHealth on care model (physician-supervised, app-enabled, GLP-1 capable), buyer segment (self-insured employers), and outcomes-driven value proposition; Virta is more diabetes-anchored and has raised substantial capital.
- Calibrate: Telehealth obesity treatment combining clinician care, GLP-1 prescribing, and behavior change; sells to employers and directly to consumers. Directly comparable to FlyteHealth on obesity-specific care model and GLP-1 stewardship; Calibrate's hybrid D2C + B2B model differs from FlyteHealth's enterprise-first GTM.
- Wondr Health: Digital weight management and metabolic health program sold primarily through self-insured employers and benefits brokers. Overlaps directly with FlyteHealth on employer GTM, broker distribution, and behavioral + clinical weight-loss approach; Wondr is more lifestyle-behavioral and less clinically intensive on GLP-1 management.
- Vida Health: Virtual chronic condition management platform covering diabetes, hypertension, weight, and mental health, sold to employers and health plans. Overlaps with FlyteHealth on cardiometabolic scope, employer channel, and AI-augmented coaching; Vida is broader across chronic conditions and less GLP-1-stewardship-focused.
Broad incumbents
- Noom: Established digital weight management platform with employer (Noom for Work) and direct-to-consumer offerings, now offering GLP-1-inclusive programs. Comparable to FlyteHealth on employer weight-management GTM and digital-first delivery; Noom is a broad incumbent with a much larger consumer brand and broader chronic-condition footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
FlyteHealth social profiles
Digital presenceFlyteHealth compliance and trust
Trust signalCompliance3 records
FlyteHealth financial estimates
Financial estimateRevenue estimate
Valuation estimate
FlyteHealth leadership team
Management profileNumber of profiles
Profiles4 records
FlyteHealth funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FlyteHealth M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FlyteHealth
What does FlyteHealth do?
FlyteHealth provides an AI-driven early cardio-kidney-metabolic (eCKM) care platform that delivers comprehensive obesity and cardiometabolic treatment to populations covered by self-insured employers, health plans, and government plans. The offering combines patent-pending Flyte Intelligence prescribing algorithms with a multidisciplinary clinical care team (board-certified obesity medicine physicians, dietitians, and behavioral support) and a patient-facing mobile app, sold on a per-covered-life subscription basis with documented outcomes of 13–16% average weight loss at 12 months and measurable pharmacy cost avoidance.
Is FlyteHealth a public or private company?
FlyteHealth is a private company. It is classified as venture growth investor backed and is currently operating.
When was FlyteHealth founded?
FlyteHealth was founded in 2012. It employs 51 to 100 people.
Where is FlyteHealth based?
FlyteHealth is headquartered in New Canaan, United States, in the North America region.
How does FlyteHealth make money?
One revenue line is on record: subscription/Per Covered Life.
Who are FlyteHealth's main competitors?
Emerging players on record are Ilant Health and Mochi Health. Direct peers are Omada Health, Found, Form Health, Virta Health, Calibrate, Wondr Health and Vida Health. Noom is listed as a broad incumbent.
Does FlyteHealth have an API?
No public API is recorded for FlyteHealth.
What industry is FlyteHealth in?
FlyteHealth's product category is Obesity and Cardiometabolic Care Services. Its primary akta.pro industry code is HLAKADAL, Obesity Medicine & Weight Management, with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 812191 and its SIC code is 8011.